nodes	percent_of_prediction	percent_of_DWPC	metapath
Flutamide—AHR—Leflunomide—systemic scleroderma	0.692	0.843	CbGbCtD
Flutamide—CYP1A2—Pentoxifylline—systemic scleroderma	0.0339	0.0413	CbGbCtD
Flutamide—CYP1A2—Leflunomide—systemic scleroderma	0.0323	0.0394	CbGbCtD
Flutamide—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0268	0.0327	CbGbCtD
Flutamide—CYP2C19—Prednisone—systemic scleroderma	0.0173	0.0211	CbGbCtD
Flutamide—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0105	0.0127	CbGbCtD
Flutamide—CYP3A4—Prednisone—systemic scleroderma	0.00837	0.0102	CbGbCtD
Flutamide—AHR—smooth muscle tissue—systemic scleroderma	0.000562	0.0902	CbGeAlD
Flutamide—AHR—digestive system—systemic scleroderma	0.000444	0.0712	CbGeAlD
Flutamide—AHR—tendon—systemic scleroderma	0.000422	0.0677	CbGeAlD
Flutamide—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.000421	0.00243	CcSEcCtD
Flutamide—Anorexia—Mometasone—systemic scleroderma	0.00042	0.00243	CcSEcCtD
Flutamide—Jaundice—Lisinopril—systemic scleroderma	0.000419	0.00242	CcSEcCtD
Flutamide—Ecchymosis—Prednisone—systemic scleroderma	0.000412	0.00238	CcSEcCtD
Flutamide—Haematuria—Lisinopril—systemic scleroderma	0.00041	0.00237	CcSEcCtD
Flutamide—Ulcer—Methotrexate—systemic scleroderma	0.000403	0.00233	CcSEcCtD
Flutamide—Discomfort—Captopril—systemic scleroderma	0.000399	0.0023	CcSEcCtD
Flutamide—Confusional state—Captopril—systemic scleroderma	0.00039	0.00225	CcSEcCtD
Flutamide—Erectile dysfunction—Mycophenolate mofetil—systemic scleroderma	0.000389	0.00225	CcSEcCtD
Flutamide—Hepatitis—Lisinopril—systemic scleroderma	0.000386	0.00223	CcSEcCtD
Flutamide—Ill-defined disorder—Azathioprine—systemic scleroderma	0.000384	0.00222	CcSEcCtD
Flutamide—Decreased appetite—Mometasone—systemic scleroderma	0.000383	0.00221	CcSEcCtD
Flutamide—Anaemia—Azathioprine—systemic scleroderma	0.000382	0.00221	CcSEcCtD
Flutamide—Pulmonary embolism—Methotrexate—systemic scleroderma	0.000381	0.0022	CcSEcCtD
Flutamide—Hyperglycaemia—Mycophenolate mofetil—systemic scleroderma	0.000381	0.0022	CcSEcCtD
Flutamide—Diabetes mellitus—Prednisone—systemic scleroderma	0.000381	0.0022	CcSEcCtD
Flutamide—Oedema peripheral—Lisinopril—systemic scleroderma	0.00038	0.0022	CcSEcCtD
Flutamide—Fatigue—Mometasone—systemic scleroderma	0.00038	0.00219	CcSEcCtD
Flutamide—Thrombocytopenia—Captopril—systemic scleroderma	0.000379	0.00219	CcSEcCtD
Flutamide—Malaise—Azathioprine—systemic scleroderma	0.000373	0.00216	CcSEcCtD
Flutamide—Cystitis noninfective—Methotrexate—systemic scleroderma	0.000372	0.00215	CcSEcCtD
Flutamide—AHR—lung—systemic scleroderma	0.00037	0.0594	CbGeAlD
Flutamide—Leukopenia—Azathioprine—systemic scleroderma	0.00037	0.00214	CcSEcCtD
Flutamide—Anorexia—Captopril—systemic scleroderma	0.000369	0.00213	CcSEcCtD
Flutamide—Cystitis—Methotrexate—systemic scleroderma	0.000368	0.00213	CcSEcCtD
Flutamide—Jaundice—Mycophenolate mofetil—systemic scleroderma	0.000367	0.00212	CcSEcCtD
Flutamide—Asthenia—Pentoxifylline—systemic scleroderma	0.000366	0.00212	CcSEcCtD
Flutamide—Tension—Mycophenolic acid—systemic scleroderma	0.000366	0.00211	CcSEcCtD
Flutamide—Ill-defined disorder—Leflunomide—systemic scleroderma	0.000363	0.0021	CcSEcCtD
Flutamide—Nervousness—Mycophenolic acid—systemic scleroderma	0.000362	0.00209	CcSEcCtD
Flutamide—Pruritus—Pentoxifylline—systemic scleroderma	0.000361	0.00209	CcSEcCtD
Flutamide—Anaemia—Leflunomide—systemic scleroderma	0.000361	0.00209	CcSEcCtD
Flutamide—Haematuria—Mycophenolate mofetil—systemic scleroderma	0.000359	0.00207	CcSEcCtD
Flutamide—Increased appetite—Prednisone—systemic scleroderma	0.000352	0.00204	CcSEcCtD
Flutamide—Malaise—Leflunomide—systemic scleroderma	0.000352	0.00204	CcSEcCtD
Flutamide—Insomnia—Captopril—systemic scleroderma	0.00035	0.00202	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.00035	0.00202	CcSEcCtD
Flutamide—Leukopenia—Leflunomide—systemic scleroderma	0.00035	0.00202	CcSEcCtD
Flutamide—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000349	0.00202	CcSEcCtD
Flutamide—Discomfort—Azathioprine—systemic scleroderma	0.000348	0.00201	CcSEcCtD
Flutamide—Ill-defined disorder—Mycophenolic acid—systemic scleroderma	0.000346	0.002	CcSEcCtD
Flutamide—Neoplasm—Methotrexate—systemic scleroderma	0.000345	0.00199	CcSEcCtD
Flutamide—Ecchymosis—Methotrexate—systemic scleroderma	0.000345	0.00199	CcSEcCtD
Flutamide—Bladder pain—Methotrexate—systemic scleroderma	0.000345	0.00199	CcSEcCtD
Flutamide—Anaemia—Mycophenolic acid—systemic scleroderma	0.000344	0.00199	CcSEcCtD
Flutamide—Somnolence—Captopril—systemic scleroderma	0.000344	0.00199	CcSEcCtD
Flutamide—Gynaecomastia—Methotrexate—systemic scleroderma	0.000341	0.00197	CcSEcCtD
Flutamide—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.000338	0.00195	CcSEcCtD
Flutamide—Dizziness—Pentoxifylline—systemic scleroderma	0.000338	0.00195	CcSEcCtD
Flutamide—Hypertension—Leflunomide—systemic scleroderma	0.000337	0.00195	CcSEcCtD
Flutamide—Decreased appetite—Captopril—systemic scleroderma	0.000336	0.00194	CcSEcCtD
Flutamide—Malaise—Mycophenolic acid—systemic scleroderma	0.000336	0.00194	CcSEcCtD
Flutamide—Erythema—Lisinopril—systemic scleroderma	0.000336	0.00194	CcSEcCtD
Flutamide—Leukopenia—Mycophenolic acid—systemic scleroderma	0.000334	0.00193	CcSEcCtD
Flutamide—Fatigue—Captopril—systemic scleroderma	0.000334	0.00193	CcSEcCtD
Flutamide—Oedema peripheral—Mycophenolate mofetil—systemic scleroderma	0.000333	0.00192	CcSEcCtD
Flutamide—Anxiety—Leflunomide—systemic scleroderma	0.000331	0.00192	CcSEcCtD
Flutamide—Constipation—Captopril—systemic scleroderma	0.000331	0.00191	CcSEcCtD
Flutamide—Thrombocytopenia—Azathioprine—systemic scleroderma	0.000331	0.00191	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.00033	0.00191	CcSEcCtD
Flutamide—Tension—Lisinopril—systemic scleroderma	0.000329	0.0019	CcSEcCtD
Flutamide—Discomfort—Leflunomide—systemic scleroderma	0.000329	0.0019	CcSEcCtD
Flutamide—Skin disorder—Azathioprine—systemic scleroderma	0.000328	0.0019	CcSEcCtD
Flutamide—Nervousness—Lisinopril—systemic scleroderma	0.000326	0.00188	CcSEcCtD
Flutamide—Vomiting—Pentoxifylline—systemic scleroderma	0.000325	0.00188	CcSEcCtD
Flutamide—Rash—Pentoxifylline—systemic scleroderma	0.000322	0.00186	CcSEcCtD
Flutamide—Hypertension—Mycophenolic acid—systemic scleroderma	0.000322	0.00186	CcSEcCtD
Flutamide—Dermatitis—Pentoxifylline—systemic scleroderma	0.000322	0.00186	CcSEcCtD
Flutamide—CYP1B1—connective tissue—systemic scleroderma	0.00032	0.0513	CbGeAlD
Flutamide—Headache—Pentoxifylline—systemic scleroderma	0.00032	0.00185	CcSEcCtD
Flutamide—Feeling abnormal—Captopril—systemic scleroderma	0.000319	0.00184	CcSEcCtD
Flutamide—Diabetes mellitus—Methotrexate—systemic scleroderma	0.000318	0.00184	CcSEcCtD
Flutamide—Anxiety—Mycophenolic acid—systemic scleroderma	0.000316	0.00183	CcSEcCtD
Flutamide—Asthenia—Mometasone—systemic scleroderma	0.000316	0.00183	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.000315	0.00182	CcSEcCtD
Flutamide—Discomfort—Mycophenolic acid—systemic scleroderma	0.000314	0.00181	CcSEcCtD
Flutamide—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000312	0.0018	CcSEcCtD
Flutamide—Pruritus—Mometasone—systemic scleroderma	0.000312	0.0018	CcSEcCtD
Flutamide—Ill-defined disorder—Lisinopril—systemic scleroderma	0.000311	0.0018	CcSEcCtD
Flutamide—Anaemia—Lisinopril—systemic scleroderma	0.00031	0.00179	CcSEcCtD
Flutamide—Skin disorder—Leflunomide—systemic scleroderma	0.00031	0.00179	CcSEcCtD
Flutamide—Confusional state—Mycophenolic acid—systemic scleroderma	0.000307	0.00177	CcSEcCtD
Flutamide—Oedema—Mycophenolic acid—systemic scleroderma	0.000304	0.00176	CcSEcCtD
Flutamide—Anorexia—Leflunomide—systemic scleroderma	0.000304	0.00176	CcSEcCtD
Flutamide—Nausea—Pentoxifylline—systemic scleroderma	0.000303	0.00175	CcSEcCtD
Flutamide—AR—connective tissue—systemic scleroderma	0.000303	0.0486	CbGeAlD
Flutamide—Malaise—Lisinopril—systemic scleroderma	0.000303	0.00175	CcSEcCtD
Flutamide—Diarrhoea—Mometasone—systemic scleroderma	0.000301	0.00174	CcSEcCtD
Flutamide—Leukopenia—Lisinopril—systemic scleroderma	0.000301	0.00174	CcSEcCtD
Flutamide—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000298	0.00172	CcSEcCtD
Flutamide—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000295	0.00171	CcSEcCtD
Flutamide—CYP1B1—smooth muscle tissue—systemic scleroderma	0.000293	0.047	CbGeAlD
Flutamide—Anorexia—Mycophenolic acid—systemic scleroderma	0.00029	0.00168	CcSEcCtD
Flutamide—CYP1B1—skin of body—systemic scleroderma	0.000289	0.0464	CbGeAlD
Flutamide—Tension—Mycophenolate mofetil—systemic scleroderma	0.000289	0.00167	CcSEcCtD
Flutamide—Insomnia—Leflunomide—systemic scleroderma	0.000288	0.00167	CcSEcCtD
Flutamide—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000286	0.00165	CcSEcCtD
Flutamide—Anxiety—Lisinopril—systemic scleroderma	0.000285	0.00165	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000284	0.00164	CcSEcCtD
Flutamide—Discomfort—Lisinopril—systemic scleroderma	0.000282	0.00163	CcSEcCtD
Flutamide—Vomiting—Mometasone—systemic scleroderma	0.00028	0.00162	CcSEcCtD
Flutamide—Feeling abnormal—Azathioprine—systemic scleroderma	0.000278	0.00161	CcSEcCtD
Flutamide—Rash—Mometasone—systemic scleroderma	0.000278	0.00161	CcSEcCtD
Flutamide—Asthenia—Captopril—systemic scleroderma	0.000278	0.0016	CcSEcCtD
Flutamide—Dermatitis—Mometasone—systemic scleroderma	0.000277	0.0016	CcSEcCtD
Flutamide—Decreased appetite—Leflunomide—systemic scleroderma	0.000277	0.0016	CcSEcCtD
Flutamide—AR—smooth muscle tissue—systemic scleroderma	0.000277	0.0445	CbGeAlD
Flutamide—Confusional state—Lisinopril—systemic scleroderma	0.000276	0.0016	CcSEcCtD
Flutamide—Headache—Mometasone—systemic scleroderma	0.000276	0.00159	CcSEcCtD
Flutamide—Insomnia—Mycophenolic acid—systemic scleroderma	0.000275	0.00159	CcSEcCtD
Flutamide—Fatigue—Leflunomide—systemic scleroderma	0.000275	0.00159	CcSEcCtD
Flutamide—Oedema—Lisinopril—systemic scleroderma	0.000274	0.00158	CcSEcCtD
Flutamide—Pruritus—Captopril—systemic scleroderma	0.000274	0.00158	CcSEcCtD
Flutamide—AR—skin of body—systemic scleroderma	0.000274	0.0439	CbGeAlD
Flutamide—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000273	0.00158	CcSEcCtD
Flutamide—Constipation—Leflunomide—systemic scleroderma	0.000273	0.00158	CcSEcCtD
Flutamide—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000272	0.00157	CcSEcCtD
Flutamide—Somnolence—Mycophenolic acid—systemic scleroderma	0.00027	0.00156	CcSEcCtD
Flutamide—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000268	0.00155	CcSEcCtD
Flutamide—Skin disorder—Lisinopril—systemic scleroderma	0.000266	0.00154	CcSEcCtD
Flutamide—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000265	0.00153	CcSEcCtD
Flutamide—Diarrhoea—Captopril—systemic scleroderma	0.000265	0.00153	CcSEcCtD
Flutamide—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000264	0.00153	CcSEcCtD
Flutamide—Erectile dysfunction—Prednisone—systemic scleroderma	0.000264	0.00152	CcSEcCtD
Flutamide—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000263	0.00152	CcSEcCtD
Flutamide—Feeling abnormal—Leflunomide—systemic scleroderma	0.000263	0.00152	CcSEcCtD
Flutamide—Fatigue—Mycophenolic acid—systemic scleroderma	0.000262	0.00152	CcSEcCtD
Flutamide—Nausea—Mometasone—systemic scleroderma	0.000262	0.00151	CcSEcCtD
Flutamide—Anorexia—Lisinopril—systemic scleroderma	0.000261	0.00151	CcSEcCtD
Flutamide—Constipation—Mycophenolic acid—systemic scleroderma	0.00026	0.0015	CcSEcCtD
Flutamide—Hyperglycaemia—Prednisone—systemic scleroderma	0.000258	0.00149	CcSEcCtD
Flutamide—Dizziness—Captopril—systemic scleroderma	0.000256	0.00148	CcSEcCtD
Flutamide—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000254	0.00147	CcSEcCtD
Flutamide—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000251	0.00145	CcSEcCtD
Flutamide—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.00025	0.00144	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000249	0.00144	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000249	0.00144	CcSEcCtD
Flutamide—Insomnia—Lisinopril—systemic scleroderma	0.000248	0.00143	CcSEcCtD
Flutamide—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000247	0.00143	CcSEcCtD
Flutamide—Vomiting—Captopril—systemic scleroderma	0.000246	0.00142	CcSEcCtD
Flutamide—Rash—Captopril—systemic scleroderma	0.000244	0.00141	CcSEcCtD
Flutamide—Dermatitis—Captopril—systemic scleroderma	0.000244	0.00141	CcSEcCtD
Flutamide—Somnolence—Lisinopril—systemic scleroderma	0.000244	0.00141	CcSEcCtD
Flutamide—Headache—Captopril—systemic scleroderma	0.000242	0.0014	CcSEcCtD
Flutamide—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000242	0.0014	CcSEcCtD
Flutamide—Oedema—Mycophenolate mofetil—systemic scleroderma	0.00024	0.00139	CcSEcCtD
Flutamide—Decreased appetite—Lisinopril—systemic scleroderma	0.000238	0.00138	CcSEcCtD
Flutamide—Fatigue—Lisinopril—systemic scleroderma	0.000236	0.00137	CcSEcCtD
Flutamide—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000235	0.00136	CcSEcCtD
Flutamide—Constipation—Lisinopril—systemic scleroderma	0.000234	0.00135	CcSEcCtD
Flutamide—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000233	0.00135	CcSEcCtD
Flutamide—CYP1B1—digestive system—systemic scleroderma	0.000231	0.0371	CbGeAlD
Flutamide—Diarrhoea—Azathioprine—systemic scleroderma	0.000231	0.00134	CcSEcCtD
Flutamide—Nausea—Captopril—systemic scleroderma	0.00023	0.00133	CcSEcCtD
Flutamide—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000229	0.00132	CcSEcCtD
Flutamide—Asthenia—Leflunomide—systemic scleroderma	0.000229	0.00132	CcSEcCtD
Flutamide—Feeling abnormal—Lisinopril—systemic scleroderma	0.000226	0.0013	CcSEcCtD
Flutamide—Pruritus—Leflunomide—systemic scleroderma	0.000226	0.0013	CcSEcCtD
Flutamide—Dizziness—Azathioprine—systemic scleroderma	0.000223	0.00129	CcSEcCtD
Flutamide—Erectile dysfunction—Methotrexate—systemic scleroderma	0.00022	0.00127	CcSEcCtD
Flutamide—CYP1B1—tendon—systemic scleroderma	0.00022	0.0353	CbGeAlD
Flutamide—AR—digestive system—systemic scleroderma	0.000219	0.0351	CbGeAlD
Flutamide—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000218	0.00126	CcSEcCtD
Flutamide—Asthenia—Mycophenolic acid—systemic scleroderma	0.000218	0.00126	CcSEcCtD
Flutamide—Diarrhoea—Leflunomide—systemic scleroderma	0.000218	0.00126	CcSEcCtD
Flutamide—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000217	0.00125	CcSEcCtD
Flutamide—Pruritus—Mycophenolic acid—systemic scleroderma	0.000215	0.00124	CcSEcCtD
Flutamide—Vomiting—Azathioprine—systemic scleroderma	0.000215	0.00124	CcSEcCtD
Flutamide—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000213	0.00123	CcSEcCtD
Flutamide—Drowsiness—Methotrexate—systemic scleroderma	0.000213	0.00123	CcSEcCtD
Flutamide—Rash—Azathioprine—systemic scleroderma	0.000213	0.00123	CcSEcCtD
Flutamide—Dermatitis—Azathioprine—systemic scleroderma	0.000213	0.00123	CcSEcCtD
Flutamide—Headache—Azathioprine—systemic scleroderma	0.000212	0.00122	CcSEcCtD
Flutamide—Dizziness—Leflunomide—systemic scleroderma	0.000211	0.00122	CcSEcCtD
Flutamide—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000209	0.00121	CcSEcCtD
Flutamide—AR—tendon—systemic scleroderma	0.000208	0.0334	CbGeAlD
Flutamide—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000208	0.0012	CcSEcCtD
Flutamide—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000205	0.00119	CcSEcCtD
Flutamide—CYP1A1—skin of body—systemic scleroderma	0.000204	0.0328	CbGeAlD
Flutamide—Haematuria—Methotrexate—systemic scleroderma	0.000203	0.00118	CcSEcCtD
Flutamide—Vomiting—Leflunomide—systemic scleroderma	0.000203	0.00117	CcSEcCtD
Flutamide—CYP2C19—digestive system—systemic scleroderma	0.000203	0.0325	CbGeAlD
Flutamide—Dizziness—Mycophenolic acid—systemic scleroderma	0.000201	0.00116	CcSEcCtD
Flutamide—Rash—Leflunomide—systemic scleroderma	0.000201	0.00116	CcSEcCtD
Flutamide—Dermatitis—Leflunomide—systemic scleroderma	0.000201	0.00116	CcSEcCtD
Flutamide—Nausea—Azathioprine—systemic scleroderma	0.000201	0.00116	CcSEcCtD
Flutamide—Headache—Leflunomide—systemic scleroderma	0.0002	0.00115	CcSEcCtD
Flutamide—Erythema—Prednisone—systemic scleroderma	0.000199	0.00115	CcSEcCtD
Flutamide—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000198	0.00114	CcSEcCtD
Flutamide—Asthenia—Lisinopril—systemic scleroderma	0.000197	0.00114	CcSEcCtD
Flutamide—Pruritus—Lisinopril—systemic scleroderma	0.000194	0.00112	CcSEcCtD
Flutamide—Vomiting—Mycophenolic acid—systemic scleroderma	0.000193	0.00112	CcSEcCtD
Flutamide—CYP1B1—lung—systemic scleroderma	0.000193	0.031	CbGeAlD
Flutamide—Rash—Mycophenolic acid—systemic scleroderma	0.000192	0.00111	CcSEcCtD
Flutamide—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000192	0.00111	CcSEcCtD
Flutamide—Hepatitis—Methotrexate—systemic scleroderma	0.000191	0.00111	CcSEcCtD
Flutamide—Headache—Mycophenolic acid—systemic scleroderma	0.000191	0.0011	CcSEcCtD
Flutamide—Nausea—Leflunomide—systemic scleroderma	0.000189	0.00109	CcSEcCtD
Flutamide—Diarrhoea—Lisinopril—systemic scleroderma	0.000187	0.00108	CcSEcCtD
Flutamide—Ill-defined disorder—Prednisone—systemic scleroderma	0.000185	0.00107	CcSEcCtD
Flutamide—Anaemia—Prednisone—systemic scleroderma	0.000184	0.00107	CcSEcCtD
Flutamide—AR—lung—systemic scleroderma	0.000183	0.0293	CbGeAlD
Flutamide—Dizziness—Lisinopril—systemic scleroderma	0.000181	0.00105	CcSEcCtD
Flutamide—Nausea—Mycophenolic acid—systemic scleroderma	0.000181	0.00104	CcSEcCtD
Flutamide—Malaise—Prednisone—systemic scleroderma	0.00018	0.00104	CcSEcCtD
Flutamide—Vomiting—Lisinopril—systemic scleroderma	0.000174	0.00101	CcSEcCtD
Flutamide—Rash—Lisinopril—systemic scleroderma	0.000173	0.000998	CcSEcCtD
Flutamide—Dermatitis—Lisinopril—systemic scleroderma	0.000173	0.000998	CcSEcCtD
Flutamide—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000172	0.000995	CcSEcCtD
Flutamide—Hypertension—Prednisone—systemic scleroderma	0.000172	0.000995	CcSEcCtD
Flutamide—Headache—Lisinopril—systemic scleroderma	0.000172	0.000992	CcSEcCtD
Flutamide—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00017	0.000982	CcSEcCtD
Flutamide—Anxiety—Prednisone—systemic scleroderma	0.000169	0.000978	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000169	0.000974	CcSEcCtD
Flutamide—Discomfort—Prednisone—systemic scleroderma	0.000168	0.000969	CcSEcCtD
Flutamide—Erythema—Methotrexate—systemic scleroderma	0.000167	0.000963	CcSEcCtD
Flutamide—CYP1A2—digestive system—systemic scleroderma	0.000166	0.0266	CbGeAlD
Flutamide—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000164	0.000949	CcSEcCtD
Flutamide—CYP1A1—digestive system—systemic scleroderma	0.000163	0.0262	CbGeAlD
Flutamide—Nausea—Lisinopril—systemic scleroderma	0.000163	0.000941	CcSEcCtD
Flutamide—Oedema—Prednisone—systemic scleroderma	0.000163	0.000941	CcSEcCtD
Flutamide—CYP3A5—digestive system—systemic scleroderma	0.00016	0.0256	CbGeAlD
Flutamide—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000159	0.000918	CcSEcCtD
Flutamide—Skin disorder—Prednisone—systemic scleroderma	0.000158	0.000914	CcSEcCtD
Flutamide—Anorexia—Prednisone—systemic scleroderma	0.000155	0.000897	CcSEcCtD
Flutamide—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000155	0.000894	CcSEcCtD
Flutamide—Anaemia—Methotrexate—systemic scleroderma	0.000154	0.00089	CcSEcCtD
Flutamide—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000153	0.000882	CcSEcCtD
Flutamide—Rash—Mycophenolate mofetil—systemic scleroderma	0.000151	0.000875	CcSEcCtD
Flutamide—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000151	0.000874	CcSEcCtD
Flutamide—Headache—Mycophenolate mofetil—systemic scleroderma	0.00015	0.000869	CcSEcCtD
Flutamide—Malaise—Methotrexate—systemic scleroderma	0.00015	0.000869	CcSEcCtD
Flutamide—Leukopenia—Methotrexate—systemic scleroderma	0.000149	0.000862	CcSEcCtD
Flutamide—Insomnia—Prednisone—systemic scleroderma	0.000147	0.000851	CcSEcCtD
Flutamide—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000143	0.000824	CcSEcCtD
Flutamide—Decreased appetite—Prednisone—systemic scleroderma	0.000141	0.000818	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000141	0.000814	CcSEcCtD
Flutamide—Fatigue—Prednisone—systemic scleroderma	0.00014	0.000811	CcSEcCtD
Flutamide—Discomfort—Methotrexate—systemic scleroderma	0.00014	0.00081	CcSEcCtD
Flutamide—Constipation—Prednisone—systemic scleroderma	0.000139	0.000804	CcSEcCtD
Flutamide—CYP1A2—lung—systemic scleroderma	0.000138	0.0222	CbGeAlD
Flutamide—Confusional state—Methotrexate—systemic scleroderma	0.000137	0.000793	CcSEcCtD
Flutamide—CYP1A1—lung—systemic scleroderma	0.000136	0.0219	CbGeAlD
Flutamide—Feeling abnormal—Prednisone—systemic scleroderma	0.000134	0.000775	CcSEcCtD
Flutamide—CYP3A5—lung—systemic scleroderma	0.000133	0.0214	CbGeAlD
Flutamide—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000133	0.00077	CcSEcCtD
Flutamide—Skin disorder—Methotrexate—systemic scleroderma	0.000132	0.000763	CcSEcCtD
Flutamide—Anorexia—Methotrexate—systemic scleroderma	0.00013	0.000749	CcSEcCtD
Flutamide—Insomnia—Methotrexate—systemic scleroderma	0.000123	0.000711	CcSEcCtD
Flutamide—Somnolence—Methotrexate—systemic scleroderma	0.000121	0.000699	CcSEcCtD
Flutamide—CYP3A4—digestive system—systemic scleroderma	0.00012	0.0192	CbGeAlD
Flutamide—Decreased appetite—Methotrexate—systemic scleroderma	0.000118	0.000683	CcSEcCtD
Flutamide—Fatigue—Methotrexate—systemic scleroderma	0.000117	0.000678	CcSEcCtD
Flutamide—Asthenia—Prednisone—systemic scleroderma	0.000117	0.000675	CcSEcCtD
Flutamide—Pruritus—Prednisone—systemic scleroderma	0.000115	0.000665	CcSEcCtD
Flutamide—Feeling abnormal—Methotrexate—systemic scleroderma	0.000112	0.000648	CcSEcCtD
Flutamide—Diarrhoea—Prednisone—systemic scleroderma	0.000111	0.000644	CcSEcCtD
Flutamide—Dizziness—Prednisone—systemic scleroderma	0.000108	0.000622	CcSEcCtD
Flutamide—Vomiting—Prednisone—systemic scleroderma	0.000103	0.000598	CcSEcCtD
Flutamide—Rash—Prednisone—systemic scleroderma	0.000103	0.000593	CcSEcCtD
Flutamide—Dermatitis—Prednisone—systemic scleroderma	0.000103	0.000592	CcSEcCtD
Flutamide—Headache—Prednisone—systemic scleroderma	0.000102	0.000589	CcSEcCtD
Flutamide—Asthenia—Methotrexate—systemic scleroderma	9.76e-05	0.000564	CcSEcCtD
Flutamide—Nausea—Prednisone—systemic scleroderma	9.67e-05	0.000559	CcSEcCtD
Flutamide—Pruritus—Methotrexate—systemic scleroderma	9.62e-05	0.000556	CcSEcCtD
Flutamide—Diarrhoea—Methotrexate—systemic scleroderma	9.3e-05	0.000538	CcSEcCtD
Flutamide—Dizziness—Methotrexate—systemic scleroderma	8.99e-05	0.00052	CcSEcCtD
Flutamide—Vomiting—Methotrexate—systemic scleroderma	8.65e-05	0.0005	CcSEcCtD
Flutamide—Rash—Methotrexate—systemic scleroderma	8.57e-05	0.000496	CcSEcCtD
Flutamide—Dermatitis—Methotrexate—systemic scleroderma	8.57e-05	0.000495	CcSEcCtD
Flutamide—Headache—Methotrexate—systemic scleroderma	8.52e-05	0.000492	CcSEcCtD
Flutamide—Nausea—Methotrexate—systemic scleroderma	8.08e-05	0.000467	CcSEcCtD
